These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35015881)

  • 1. New life for an old therapy: ELTD1 as a downstream target of angiogenesis.
    Tiek DM; Cheng SY
    Neuro Oncol; 2022 Mar; 24(3):412-413. PubMed ID: 35015881
    [No Abstract]   [Full Text] [Related]  

  • 2. A review of ELTD1, a pro-angiogenic adhesion GPCR.
    Favara DM; Banham AH; Harris AL
    Biochem Soc Trans; 2014 Dec; 42(6):1658-64. PubMed ID: 25399586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ELTD1, an effective anti-angiogenic target for gliomas: preclinical assessment in mouse GL261 and human G55 xenograft glioma models.
    Ziegler J; Pody R; Coutinho de Souza P; Evans B; Saunders D; Smith N; Mallory S; Njoku C; Dong Y; Chen H; Dong J; Lerner M; Mian O; Tummala S; Battiste J; Fung KM; Wren JD; Towner RA
    Neuro Oncol; 2017 Feb; 19(2):175-185. PubMed ID: 27416955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A core human primary tumor angiogenesis signature identifies the endothelial orphan receptor ELTD1 as a key regulator of angiogenesis.
    Masiero M; Simões FC; Han HD; Snell C; Peterkin T; Bridges E; Mangala LS; Wu SY; Pradeep S; Li D; Han C; Dalton H; Lopez-Berestein G; Tuynman JB; Mortensen N; Li JL; Patient R; Sood AK; Banham AH; Harris AL; Buffa FM
    Cancer Cell; 2013 Aug; 24(2):229-41. PubMed ID: 23871637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ELTD1-An Emerging Silent Actor in Cancer Drama Play.
    Sevastre AS; Buzatu IM; Baloi C; Oprita A; Dragoi A; Tataranu LG; Alexandru O; Tudorache S; Dricu A
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34068040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of an ELTD1 knockout human embryonic stem cell line by the iCRISPR/Cas9 system.
    Luo Q; Wei C; Long Y; Zhang M; Shan W; Li H; Cai S; Xu Y; Qian P; Huang H
    Stem Cell Res; 2021 May; 53():102350. PubMed ID: 34087984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor endothelial ELTD1 as a predictive marker for treatment of renal cancer patients with sunitinib.
    Niinivirta M; Georganaki M; Enblad G; Lindskog C; Dimberg A; Ullenhag GJ
    BMC Cancer; 2020 Apr; 20(1):339. PubMed ID: 32321460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ELTD1 promotes invasion and metastasis by activating MMP2 in colorectal cancer.
    Sun J; Zhang Z; Chen J; Xue M; Pan X
    Int J Biol Sci; 2021; 17(12):3048-3058. PubMed ID: 34421349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A tale of two multi-focal therapies for glioblastoma: An antibody targeting ELTD1 and nitrone-based OKN-007.
    Zalles M; Smith N; Saunders D; Lerner M; Fung KM; Battiste J; Towner RA
    J Cell Mol Med; 2022 Jan; 26(2):570-582. PubMed ID: 34910361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ELTD1 deletion reduces vascular abnormality and improves T-cell recruitment after PD-1 blockade in glioma.
    Huang H; Georganaki M; Conze LL; Laviña B; van Hooren L; Vemuri K; van de Walle T; Ramachandran M; Zhang L; Pontén F; Bergqvist M; Smits A; Betsholtz C; Dejana E; Magnusson PU; He L; Lugano R; Dimberg A
    Neuro Oncol; 2022 Mar; 24(3):398-411. PubMed ID: 34347079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor, latrophilin, and seven transmembrane domain-containing protein 1 marker, a novel angiogenesis marker.
    Serban F; Artene SA; Georgescu AM; Purcaru SO; Tache DE; Alexandru O; Dricu A
    Onco Targets Ther; 2015; 8():3767-74. PubMed ID: 26719704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ELTD1 facilitates glioma proliferation, migration and invasion by activating JAK/STAT3/HIF-1α signaling axis.
    Li J; Shen J; Wang Z; Xu H; Wang Q; Chai S; Fu P; Huang T; Anas O; Zhao H; Li J; Xiong N
    Sci Rep; 2019 Sep; 9(1):13904. PubMed ID: 31554859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apelin/APJ system: A novel promising therapy target for pathological angiogenesis.
    Wu L; Chen L; Li L
    Clin Chim Acta; 2017 Mar; 466():78-84. PubMed ID: 28025030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmented cardiac hypertrophy in response to pressure overload in mice lacking ELTD1.
    Xiao J; Jiang H; Zhang R; Fan G; Zhang Y; Jiang D; Li H
    PLoS One; 2012; 7(5):e35779. PubMed ID: 22606234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G Protein-Coupled Receptors at the Crossroad between Physiologic and Pathologic Angiogenesis: Old Paradigms and Emerging Concepts.
    De Francesco EM; Sotgia F; Clarke RB; Lisanti MP; Maggiolini M
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29240722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ELTD1, a potential new biomarker for gliomas.
    Towner RA; Jensen RL; Colman H; Vaillant B; Smith N; Casteel R; Saunders D; Gillespie DL; Silasi-Mansat R; Lupu F; Giles CB; Wren JD
    Neurosurgery; 2013 Jan; 72(1):77-90; discussion 91. PubMed ID: 23096411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developmental vascular remodeling defects and postnatal kidney failure in mice lacking Gpr116 (Adgrf5) and Eltd1 (Adgrl4).
    Lu S; Liu S; Wietelmann A; Kojonazarov B; Atzberger A; Tang C; Schermuly RT; Gröne HJ; Offermanns S
    PLoS One; 2017; 12(8):e0183166. PubMed ID: 28806758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing of epidermal growth factor, latrophilin and seven transmembrane domain-containing protein 1 (ELTD1) via siRNA-induced cell death in glioblastoma.
    Serban F; Daianu O; Tataranu LG; Artene SA; Emami G; Georgescu AM; Alexandru O; Purcaru SO; Tache DE; Danciulescu MM; Sfredel V; Dricu A
    J Immunoassay Immunochem; 2017; 38(1):21-33. PubMed ID: 27379831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting ELTD1, an angiogenesis marker for glioblastoma (GBM), also affects VEGFR2: molecular-targeted MRI assessment.
    Ziegler J; Zalles M; Smith N; Saunders D; Lerner M; Fung KM; Patel M; Wren JD; Lupu F; Battiste J; Towner RA
    Am J Nucl Med Mol Imaging; 2019; 9(1):93-109. PubMed ID: 30911439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new link in ovarian cancer angiogenesis: lysophosphatidic acid and vascular endothelial growth factor expression.
    Folkman J
    J Natl Cancer Inst; 2001 May; 93(10):734-5. PubMed ID: 11353777
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.